Avalyn Pharma
PrivateLast Round
IPO
4/1/2026
Est. Valuation
$628M
Total Funding Raised
$373.7M
Company Overview
Avalyn Pharma is a biotechnology company focused on developing innovative therapies for idiopathic pulmonary fibrosis and severe respiratory diseases through an inhaled formulation of pirfenidone that enhances drug delivery to the lungs while minimizing side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avalyn Pharma Comps
Public and private peers based on sector, stage, and business model.
Avalyn Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | 4/1/2026 | ||||
| Series D | 7/22/2025 | ||||
| Series C | 9/27/2023 | ||||
| Series B | 4/27/2020 | ||||
| Series A | 5/15/2017 | ||||
Seed | 11/8/2012 |
Key People
Founding team and executive leadership
Avalyn Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TPG Life Sciences Innovations | Series D |
| Surveyor Capital | Series D |
| Perceptive Advisors | Series C |
| Heartland Healthcare Capital | Series C |
| Eventide Funds | Series D, Series C |
| Xontogeny | Series C |
| F-Prime Capital | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Jon Congleton joins the Board of Directors.
- Apr 1, 2026
$201M raised at a $628M valuation.
Avalyn Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avalyn Pharma's valuation, stock price, and market status.
